Effect of drainage tube placed in left thoracic cavity versus placed in mediastinum after left pleura partial resection in robot-assisted McKeown esophagectomy for esophageal carcinoma_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

XU Yang , PENG Hao , HU Liwen , QIN Tao , ZHONG Jihong , SHEN Yi ,  YI Jun

Department of Cardiothoracic Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, P. R. China;

Corresponding?author：

YI Jun, Email: njyijun@163.com

Keywords：

Esophageal cancer; mediastinal drainage tube; pleural effusion; Da Vinci surgical system; enhanced recovery after surgery

DOI：

10.7507/1007-4848.202112014

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate the effect of mediastinal drainage tube placed in the left thoracic cavity after partial resection of the mediastinum pleura in robot-assisted McKeown esophagectomy for esophageal carcinoma, and to compare it with the traditional method of mediastinal drainage tube placed in mediastinum. Methods We retrospectively analyzed clinical data of 96 patients who underwent robot-assisted McKeown esophagectomy for esophageal carcinoma by the surgeons in the same medical group in our department between July 2018 and March 2021. There were 78 males and 18 females, aged 52-79 years. Left mediastinum pleura around the carcinoma during operation was resected in all patients. Patients were divided into two groups according to the method of mediastinal drainage tube placement: a control group (placed in mediastinum) and an observation group (placed through the mediastinal pleura into the left thoracic cavity with several side ports distributed in the mediastinum). The incidence of left thoracentesis or catheterization after surgery, anastomotic fistula and anastomotic healing time, other complications such as pneumonia and postoperative pain score were also compared between the two groups. Results There was no statistical difference in baseline data or surgical parameters between the two groups. The percentage of patients in the observation group who needed re-thoracentesis or re-catheterization postoperatively due to massive pleural effusion in the left thoracic cavity was significantly lower than that in the control group (5.6% vs. 21.4%, P=0.020). The incidence of anastomotic leakage (3.7% vs. 7.1%, P=0.651) and the healing time of anastomosis (18.56±4.27 d vs. 24.33±5.48 d, P=0.304) were not statistically different between the two groups, and there was no statistical difference in other complications such as pulmonary infection. Moreover, the postoperative pain score was also similar between the two groups. Conclusion For patients whose mediastinal pleura is removed partially during robot-assisted McKeown esophagectomy for esophageal carcinoma, placing the drainage tube through the mediastinal pleura into the left thoracic cavity can reduce the risk of left-side thoracentesis or catheterization, which may promote the postoperative recovery of patients.

Citation： XU Yang, PENG Hao, HU Liwen, QIN Tao, ZHONG Jihong, SHEN Yi, YI Jun. Effect of drainage tube placed in left thoracic cavity versus placed in mediastinum after left pleura partial resection in robot-assisted McKeown esophagectomy for esophageal carcinoma. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(9): 1140-1147. doi: 10.7507/1007-4848.202112014 Copy

1.	陳飛, 王悠清. 1990—2019年中國食管癌疾病負擔及其變化趨勢分析. 中國腫瘤, 2021, 30(6): 401-407.
2.	朱多杰, 李斌, 王成, 等. 術后輔助治療對局部進展期(pT3N0M0)食管鱗癌遠期生存影響的回顧性分析. 中國腫瘤臨床, 2018, 45(5): 228-231.
3.	Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today, 2020, 50(1): 12-20.
4.	Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of life and late complications after minimally invasive compared to open esophagectomy: Results of a randomized trial. World J Surg, 2015, 39(8): 1986-1993.
5.	Sakamoto T, Fujiogi M, Matsui H, et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: A nationwide retrospective analysis. Ann Surg, 2021, 274(2): 324-330.
6.	Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol, 2017, 24(7): 1821-1827.
7.	易俊, 熊磊, 李德閩, 等. 達芬奇機器人在食管癌外科治療中的應用. 中國胸心血管外科臨床雜志, 2015, 22(10): 910-913.
8.	Tagkalos E, Goense L, Hoppe-Lotichius M, et al. Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: A propensity-matched analysis. Dis Esophagus, 2020, 33(4): doz060.
9.	徐志華, 張含露, 楊梅, 等. 達芬奇機器人與胸腹腔鏡聯合輔助McKeown食管癌根治術后患者短期疼痛的非隨機對照研究. 中國胸心血管外科臨床雜志, 2018, 25(5): 378-381.
10.	劉繼輝, 孫明, 余兵. 縱隔負壓引流管在經右胸途徑食管癌手術中的應用. 臨床外科雜志, 2021, 29(8): 714-716.
11.	孫志勇, 曹子昂, 葉清, 等. 術前運用NRS2002評估食管癌患者營養風險及臨床結局的研究. 中國胸心血管外科臨床雜志, 2015, 22(4): 323-326.
12.	許淑華, 何祺煜, 王小軍, 等. 胸腔鏡食管癌術后常見并發癥的比較分析. 東南大學學報 (醫學版), 2021, 40(1): 74-77.
13.	Sziklavari Z, Neu R, Hofmann HS, et al. Persistent pleural effusion following thoracic surgery. Chirurg, 2015, 86(5): 432-436.
14.	Xu Y, Li XK, Cong ZZ, et al. Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: A propensity score-matched study. Dis Esophagus, 2021, 34(9): doaa114.
15.	Nakahara Y, Yamasaki M, Miyazaki Y, et al. Reflux after esophagectomy with gastric conduit reconstruction in the posterior mediastinum for esophageal cancer: Original questionnaire and EORTC QLQ-C30 survey. Dis Esophagus, 2018, 31(7): 1-7.
16.	Quiding H, H?ggquist SO. Visual analogue scale and the analysis of analgesic action. Eur J Clin Pharmacol, 1983, 24(4): 475-478.
17.	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
18.	紀晨光, 劉麗, 馮志杰. 早期食管癌的內鏡下診治進展. 河北醫科大學學報, 2021, 42(6): 735-739.
19.	侯廣杰, 連戈, 郭寶峰, 等. 胸腹腔鏡聯合切除局部晚期食管癌手術視頻要點. 中國胸心血管外科臨床雜志, 2020, 27(6): 627-628.
20.	Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg, 2021, 161(3): 836-843.
21.	徐楊, 申翼. 達芬奇機器人在食管外科中的應用. 醫學研究生學報, 2021, 34(1): 1-7.
22.	范富翠, 童雅萍, 梁冠冕, 等. NRS2002結合營養指標評價食管癌術后出院患者的營養狀況. 廣東醫學, 2020, 41(19): 1970-1974.
23.	趙瀾濤, 王亮, 陳建海, 等. 經縱隔右胸腔引流管在食管癌根治術后引流效果分析. 山西醫藥雜志, 2020, 49(4): 447-449.
24.	Marshall K, McLaughlin K. Pain management in thoracic surgery. Thorac Surg Clin, 2020, 30(3): 339-346.
25.	Ashok A, Niyogi D, Ranganathan P, et al. The enhanced recovery after surgery (ERAS) protocol to promote recovery following esophageal cancer resection. Surg Today, 2020, 50(4): 323-334.
26.	Rubinkiewicz M, Witowski J, Su M, et al. Enhanced recovery after surgery (ERAS) programs for esophagectomy. J Thorac Dis, 2019, 11(Suppl 5): S685-S691.

1. 陳飛, 王悠清. 1990—2019年中國食管癌疾病負擔及其變化趨勢分析. 中國腫瘤, 2021, 30(6): 401-407.
2. 朱多杰, 李斌, 王成, 等. 術后輔助治療對局部進展期(pT3N0M0)食管鱗癌遠期生存影響的回顧性分析. 中國腫瘤臨床, 2018, 45(5): 228-231.
3. Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today, 2020, 50(1): 12-20.
4. Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of life and late complications after minimally invasive compared to open esophagectomy: Results of a randomized trial. World J Surg, 2015, 39(8): 1986-1993.
5. Sakamoto T, Fujiogi M, Matsui H, et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: A nationwide retrospective analysis. Ann Surg, 2021, 274(2): 324-330.
6. Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol, 2017, 24(7): 1821-1827.
7. 易俊, 熊磊, 李德閩, 等. 達芬奇機器人在食管癌外科治療中的應用. 中國胸心血管外科臨床雜志, 2015, 22(10): 910-913.
8. Tagkalos E, Goense L, Hoppe-Lotichius M, et al. Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: A propensity-matched analysis. Dis Esophagus, 2020, 33(4): doz060.
9. 徐志華, 張含露, 楊梅, 等. 達芬奇機器人與胸腹腔鏡聯合輔助McKeown食管癌根治術后患者短期疼痛的非隨機對照研究. 中國胸心血管外科臨床雜志, 2018, 25(5): 378-381.
10. 劉繼輝, 孫明, 余兵. 縱隔負壓引流管在經右胸途徑食管癌手術中的應用. 臨床外科雜志, 2021, 29(8): 714-716.
11. 孫志勇, 曹子昂, 葉清, 等. 術前運用NRS2002評估食管癌患者營養風險及臨床結局的研究. 中國胸心血管外科臨床雜志, 2015, 22(4): 323-326.
12. 許淑華, 何祺煜, 王小軍, 等. 胸腔鏡食管癌術后常見并發癥的比較分析. 東南大學學報 (醫學版), 2021, 40(1): 74-77.
13. Sziklavari Z, Neu R, Hofmann HS, et al. Persistent pleural effusion following thoracic surgery. Chirurg, 2015, 86(5): 432-436.
14. Xu Y, Li XK, Cong ZZ, et al. Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: A propensity score-matched study. Dis Esophagus, 2021, 34(9): doaa114.
15. Nakahara Y, Yamasaki M, Miyazaki Y, et al. Reflux after esophagectomy with gastric conduit reconstruction in the posterior mediastinum for esophageal cancer: Original questionnaire and EORTC QLQ-C30 survey. Dis Esophagus, 2018, 31(7): 1-7.
16. Quiding H, H?ggquist SO. Visual analogue scale and the analysis of analgesic action. Eur J Clin Pharmacol, 1983, 24(4): 475-478.
17. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
18. 紀晨光, 劉麗, 馮志杰. 早期食管癌的內鏡下診治進展. 河北醫科大學學報, 2021, 42(6): 735-739.
19. 侯廣杰, 連戈, 郭寶峰, 等. 胸腹腔鏡聯合切除局部晚期食管癌手術視頻要點. 中國胸心血管外科臨床雜志, 2020, 27(6): 627-628.
20. Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg, 2021, 161(3): 836-843.
21. 徐楊, 申翼. 達芬奇機器人在食管外科中的應用. 醫學研究生學報, 2021, 34(1): 1-7.
22. 范富翠, 童雅萍, 梁冠冕, 等. NRS2002結合營養指標評價食管癌術后出院患者的營養狀況. 廣東醫學, 2020, 41(19): 1970-1974.
23. 趙瀾濤, 王亮, 陳建海, 等. 經縱隔右胸腔引流管在食管癌根治術后引流效果分析. 山西醫藥雜志, 2020, 49(4): 447-449.
24. Marshall K, McLaughlin K. Pain management in thoracic surgery. Thorac Surg Clin, 2020, 30(3): 339-346.
25. Ashok A, Niyogi D, Ranganathan P, et al. The enhanced recovery after surgery (ERAS) protocol to promote recovery following esophageal cancer resection. Surg Today, 2020, 50(4): 323-334.
26. Rubinkiewicz M, Witowski J, Su M, et al. Enhanced recovery after surgery (ERAS) programs for esophagectomy. J Thorac Dis, 2019, 11(Suppl 5): S685-S691.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Effect of drainage tube placed in left thoracic cavity versus placed in mediastinum after left pleura partial resection in robot-assisted McKeown esophagectomy for esophageal carcinoma

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content